PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
27-Dec-2023 Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA Kuros Biosciences AG
22-Dec-2023 PAION AG: Sale of the business operations PAION AG
22-Dec-2023 PAION AG: Sale of the business operations PAION AG
22-Dec-2023 Attend the PharmaMarketing USA Summit in February 2024 marcusevans
22-Dec-2023 Attend the PharmaMarketing Europe Summit in March 2024 marcusevans
22-Dec-2023 Calliditas Therapeutics announces full FDA approval of TARPEYO®, the only FDA-approved treatment for IgA nephropathy to significantly reduce the loss of kidney function Calliditas Therapeutics
22-Dec-2023 Positive Outputs from Lab-Based Analysis of RSV Drug Candidates Identified Using AI Poolbeg Pharma plc
22-Dec-2023 PureTech Year End Update and Outlook for 2024 PureTech
22-Dec-2023 Xlife Sciences AG Achieves Significant Milestone in the Development of Radiodiagnostics for Liver Diseases Xlife Sciences AG
21-Dec-2023 Shareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting Evolva Holding SA
21-Dec-2023 Shareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting Evolva Holding SA
21-Dec-2023 STRATEC TO PARTICIPATE IN THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE STRATEC SE
21-Dec-2023 Adjustment of the forecast for revenue and EBITDA for FY 2023; implementation of a personnel measure to achieve positive EBITDA and balanced cash flow in the operating trauma business aap Implantate AG
20-Dec-2023 RadioGel Precision Radionuclide Therapy Receives FDA Breakthrough Device Designation Vivos Inc.
20-Dec-2023 iOmx Therapeutics attends 2024 J.P. Morgan Healthcare Conference iOmx Therapeutics AG
20-Dec-2023 Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH) M1 Kliniken AG
20-Dec-2023 DOUGLAS with record sales and earnings Douglas GmbH
20-Dec-2023 Xlife Sciences AG paves the way for the next successful out-licensing and announces cooperation with Quant Biomarkers AG for the development of advanced biomarkers for kidney diseases Xlife Sciences AG
19-Dec-2023 Almirall to participate in the 42nd Annual J.P. Morgan Healthcare Conference Almirall S.A. (BME: ALM),
19-Dec-2023 Otsuka and Ionis enter into licensing agreement covering Europe for hereditary angioedema Otsuka Pharmaceutical Europe Ltd